We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+22.53%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$1.83B
AUM Growth
+$508M
Cap. Flow
+$309M
Cap. Flow %
16.91%
Top 10 Hldgs %
53.61%
Holding
96
New
26
Increased
25
Reduced
14
Closed
27

Top Buys

Rank Stock Value
1
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$52.8M
2
CELG
Celgene Corp
CELG
+$51.8M
3
BIIB icon
Biogen
BIIB
+$47.2M
4
PCRX icon
Pacira BioSciences
PCRX
+$41.8M
5
BURL icon
Burlington
BURL
+$32.2M

Top Sells

Rank Stock Value
1
CLVS
Clovis Oncology, Inc.
CLVS
+$73.6M
2
SGI
Somnigroup International
SGI
+$34.1M
3
SRCL
Stericycle Inc
SRCL
+$31.5M
4
REGN icon
Regeneron Pharmaceuticals
REGN
+$26.1M
5
PGNX
Progenics Pharmaceuticals Inc
PGNX
+$23.9M

Sector Composition

Rank Sector Weight
1 Healthcare 35.87%
2 Consumer Discretionary 11.8%
3 Consumer Staples 6.82%
4 Industrials 4.98%
5 Communication Services 0.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ASMB icon
26
Assembly Biosciences
ASMB
$516M
$22.2M 1.22%
94,000
+85,667
+1,028% +$21.7M
HD icon
27
Home Depot
HD
$332B
$21.5M 1.18%
+112,000
New +$20.5M
SPPI
28
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$20.6M 1.13%
1,928,000
+428,000
+29% +$4.58M
ADMS
29
DELISTED
Adamas Pharmaceuticals
ADMS
$19.5M 1.07%
2,744,000
+2,086,000
+317% +$18.8M
DPLO
30
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
$17.4M 0.95%
+3,000,000
New +$31M
PTCT icon
31
PTC Therapeutics
PTCT
$6.26B
$15.1M 0.82%
400,000
+100,000
+33% +$3.36M
DKS icon
32
Dick's Sporting Goods
DKS
$17.9B
$14.7M 0.81%
+400,000
New +$14.3M
FIZZ icon
33
National Beverage
FIZZ
$3B
$14.3M 0.78%
+496,000
New +$17.6M
CLLS
34
Cellectis
CLLS
$287M
$13.4M 0.73%
728,000
+139,000
+24% +$2.46M
CPB icon
35
Campbell Soup
CPB
$6.58B
$12.7M 0.69%
+332,000
New +$11.7M
SBBP
36
DELISTED
Strongbridge Biopharma plc.
SBBP
$12.4M 0.68%
2,492,000
-386,000
-13% -$1.9M
SJM icon
37
J.M. Smucker
SJM
$13.1B
$11.7M 0.64%
100,000
-140,000
-58% -$14.6M
PRTK
38
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$11.4M 0.62%
2,124,000
+156,000
+8% +$1.01M
BLUE
39
DELISTED
bluebird bio
BLUE
$10.7M 0.59%
+5,250
New +$9.24M
FUN icon
40
Cedar Fair
FUN
$1.81B
$10.5M 0.58%
200,000
+50,000
+33% +$2.67M
JACK icon
41
Jack in the Box
JACK
$312M
$9.73M 0.53%
+120,000
New +$9.6M
NKE icon
42
Nike
NKE
$62.7B
$9.1M 0.5%
+108,000
New +$8.91M
FIVE icon
43
Five Below
FIVE
$12.1B
$8.95M 0.49%
72,000
+12,000
+20% +$1.45M
CPRX
44
DELISTED
Catalyst Pharmaceutical
CPRX
$7.75M 0.42%
1,520,000
+140,000
+10% +$412K
MRK icon
45
Merck
MRK
$321B
$7.59M 0.42%
+94,320
New +$7.05M
ACHN
46
DELISTED
Achillion Pharmaceuticals
ACHN
$7.4M 0.41%
2,500,000
-1,800,000
-42% -$4.42M
ALIM
47
DELISTED
Alimera Sciences
ALIM
$7.35M 0.4%
462,400
– –
EAT icon
48
Brinker International
EAT
$9B
$7.28M 0.4%
+164,000
New +$7.39M
AMZN icon
49
Amazon
AMZN
$2.53T
$7.12M 0.39%
+80,000
New +$6.66M
OLLI icon
50
Ollie's Bargain Outlet
OLLI
$4.4B
$6.83M 0.37%
80,000
-28,000
-26% -$2.26M
1
2
3 4

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
DCP
DSM Capital Partners Palm Beach Gardens, Florida $5.66B AUM 27.45% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return

Armistice Capital's Q1 2019 Portfolio in Review

As of Q1 2019, Armistice Capital held 96 positions worth $1.83B, up 38% from $1.32B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Armistice Capital deployed $309M of net new capital in Q1 2019, opening 26 new positions and adding to 25 existing holdings. Its largest new stake was Madrigal Pharmaceuticals: 425,000 shares worth $53.2M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 39% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

On the sell side, the largest reduction was Clovis Oncology, Inc., an estimated $73.6M trimmed.

  • Armistice Capital's largest Q1 2019 buy was Madrigal Pharmaceuticals: 425,000 shares worth $53.2M.
  • Armistice Capital added most to Target in Q1 2019, an estimated $21.9M increase.
  • Armistice Capital's biggest Q1 2019 reduction was Clovis Oncology, Inc., cutting an estimated $73.6M.
  • Armistice Capital fully exited Somnigroup International in Q1 2019, selling an estimated $34.1M.
  • Armistice Capital's ten largest holdings make up 54% of its $1.83B portfolio in Q1 2019.
  • Armistice Capital opened 26 new positions and closed 27 in Q1 2019.
  • Armistice Capital's portfolio value rose 38% quarter-over-quarter to $1.83B.

Based on Armistice Capital's 13F filing for Q1 2019, filed 15 May 2019.